Insulin for glycaemic control in acute ischaemic stroke

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 1, 2014, Pages

  Bellolio, M Fernanda ^a   Gilmore, Rachel M ^a   Ganti, Latha ^b  

^a MAYO CLINIC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

BRAIN ISCHEMIA; CONTINUOUS INFUSION; DEATH; DIABETES MELLITUS; ENTERIC FEEDING; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; LOW CARBOHYDRATE DIET; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; AGED; BLOOD; CEREBROVASCULAR ACCIDENT; FEMALE; MALE; META ANALYSIS; METABOLISM; MORTALITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE VALUES; STROKE;

EID: 84899666298     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005346.pub4     Document Type: Review

References (88)

1. Azevedo JRA, Azevedo RP, Miranda MA, Costa NNR, Araujo LO. Management of hyperglycemia in patients with acute ischemic stroke: comparison of two strategies. Critical Care 2009;13 Suppl 3:48.
2. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, et al.Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurology 2007;6:397-406.
3. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR, GRASP Investigators. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke 2009;40:3804-9.
4. Rosso C, Corvol JC, Pires C, Crozier S, Attal Y, Jacqueminet S, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke 2012;43:2343-9. [: NCT00472381; PUBMED: PMID: 22700528]
5. Kreisel SH, Berschin UM, Hammes HP, Leweling H, Bertsch T, Hennerici MG, et al.Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovascular Diseases 2009;27(2):167-75.
6. McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW. Randomized controlled trial of insulin for acute poststroke hyperglycemia. Annals of Neurology 2010;67:570-8. [PUBMED: PMID: 20437554]
7. Staszewski J, Brodacki B, Kotowicz J, Stepien A. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. Journal of Stroke and Cerebrovascular Diseases 2011;20(2):150-4. [PUBMED: PMID: 20621520]
8. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al.Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008;39:384-9.
9. Vinychuk S, Melnyk V, Margitich V. Hyperglycemia after acute ischemic stroke: prediction, significance and immediate control with insulin-potassium-saline-magnesium infusions. Heart Drug 2005;5:197-204.
10. Vriesendorp TM, Roos YB, Kruyt ND, Biessels GJ, Kappelle LJ, Vermeulen M, et al. Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke. Journal of Neurology, Neurosurgery, and Psychiatry 2009;80(9):1040-3. [PUBMED: PMID: 19684236]
11. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovascular Diseases 2006;22:116-22.
12. Lundby Christensen L, Almdal T, Boesgaard T, Breum L, Dunn E, Gade-Rasmussen B, et al.Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial. Diabetes, Obesity & Metabolism 2009;11:315-22.
13. De Azevedo JR, Silva LGS. Prognosis of neurological and neurosurgical patients submitted to prevention of hyperglycemia. Revista Brasileira de Terapia Intensiva 1997;9(2):77-81.
14. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30(4):793-9.
15. Kruyt N. Glucose regulation by continuous tube feeding and Vildagliptin in addition to insulin in hyperglycemic acute stroke patients. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1874. [: Nederlands Trial Register (http://www.trialregister.nl). 2009.]
16. Green DM, O'Phelan KH, Bassin SL, Change CWJ, Stern TS, Asai SM. Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocritical Care 2010;13:299-306.
17. Miyashita Y, Nishimura R, Nemoto M, Matsudaira T, Kurata H, Yokota T, et al.Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure. Cardiovascular Diabetology 2008;7:16.
18. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al.Glucose control and vascular complications in veterans with type 2 diabetes. New England Journal of Medicine 2009;360:129-39.
19. Gentile NT. Effect of insulin on infarct size and neurologic outcome after acute stroke. http://clinicaltrials.gov/show/NCT00373269.
20. Johnston KC. Stroke Hyperglycemia Insulin Network Effort (SHINE). ClinicalTrials.gov. [electronic database] 2011.
21. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219.
22. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999;30(1):160-70.
23. Auer RN. Insulin, blood glucose levels, and ischemic brain damage. Neurology 1998;51(3 Suppl 3):39-43.
24. Barber AA, Bernheim F. Lipid peroxidation: its measurement, occurrence, and significance in animal tissues. Advances in Gerontological Research 1967;2:355-403.
25. Barry MA, Reynolds JE, Eastman A. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Research 1993;53:2349-57.
26. Bochicchio GV, Scalea TM. Glycemic control in the ICU. Advances in Surgery 2008;42:261-75.
27. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine 2008;358(2):125-39.
28. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al.Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59(5):669. [PUBMED: 12221155]
29. Bruno A, Williams LS, Kent TA. How important is hyperglycemia during acute brain infarction?. Neurologist 2004;10(4):195-200.
30. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Archives of Neurology 1985;42:661-3.
31. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-32.
32. Combs DJ, Dempsey RJ, Donaldson D, Kindy MS. Hyperglycemia suppresses c-fos mRNA expression following transient cerebral ischemia in gerbils. Journal of Cerebral Blood Flow and Metabolism 1992;12:169-72.
33. Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. Journal of Clinical Epidemiology 1995;48:167-71.
34. Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, et al.Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005;293(4):437-46.
35. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Fatal strokes in hyperglycemic cats. Stroke 1989;20:1707-15.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
37. Farese RV Jr, Yost TJ, Eckel RH. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 1991;40(2):214. [PUBMED: 1988780]
38. Fielding BA, Frayn KN. Lipoprotein lipase and the disposition of dietary fatty acids. British Journal of Nutrition 1998;80(6):495. [PUBMED: 10211047]
39. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, et al.Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Annals of Internal Medicine 2007;146(4):233-43.
40. Gisselsson L, Smith ML, Siesjo BK. Hyperglycemia and focal brain ischemia. Journal of Cerebral Blood Flow and Metabolism 1999;19:288-97.
41. Gray CS, Taylor R, French JM, Alberti KG, Venables GS, James OF, et al.The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke. Diabetic Medicine 1987;4:237-40.
42. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. Journal of Neurosurgery 1995;82(2):262-8.
43. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
44. Hoxworth JM, Xu K, Zhou Y, Lust WD, LaManna JC. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain Research 1999;821(2):467-79.
45. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, et al.Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. European Heart Journal 2006;27(22):2716-24.
46. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994;25:1977-84.
47. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, et al.Stroke topography and outcome in relation to hyperglycaemia and diabetes. Journal of Neurology, Neurosurgery, and Psychiatry 1992;55:263-70.
48. Koistinaho J, Pasonen S, Yrjanheikki J, Chan PH. Spreading depression-induced gene expression is regulated by plasma glucose. Stroke 1999;30(1):114-9.
49. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives?. Lancet 1993;342:395-8.
50. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333:597-600.
51. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109(12):1497-502.
52. Li PA, Shuaib A, Miyashita H, He QP, Siesjo BK, Warner DS. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 2000;31(1):183-92.
53. Lin B, Ginsberg MD, Busto R. Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: microglial, astrocytic and endothelial alterations. Acta Neuropathologica 1998;96:610-20.
54. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Reviews Neuroscience 2003;4(5):399-415.
55. Melamed E. Reactive hyperglycaemia in patients with acute stroke. Journal of the Neurological Sciences 1976;29:267-75.
56. Montori VM, Swiontkowski MF, Cook DJ. Methodologic issues in systematic reviews and meta-analyses. Clinical Orthopaedics and Related Research 2003;413:43-54.
57. Murros K, Fogelholm R, Kettunen S, Vuorela AL, Valve J. Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction. Journal of the Neurological Sciences 1992;111:59-64.
58. Murros K, Fogelholmd R. Diabetes and stress hyperglycaemia in stroke. Journal of Neurology, Neurosurgery, and Psychiatry 1993;56:428.
59. Myers RE, Yamaguchi S. Nervous system effects of cardiac arrest in monkeys. Preservation of vision. Archives of Neurology 1977;34:65-74.
60. Nedergaard M. Spreading depression as a contributor to ischemic brain damage. Advances in Neurology 1996;71:75-83.
61. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine 2009;360(13):1283-97. [: ClinicalTrials identifier NCT00220987]
62. O'Neill PA, Davies I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 1991;22:842-7.
63. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al.Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Annals of Neurology 2002;52(1):20-8.
64. Prakash A, Matta BF. Hyperglycaemia and neurological injury. Current Opinion in Anaesthesiology 2008;21:565-9.
65. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982;32:1239-46.
66. Ramnanan CJ, Edgerton DS, Rivera N, Irimia-Dominguez J, Farmer B, Neal DW, et al.Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo. Diabetes 2010;59(6):1302. [PUBMED: 20185816]
67. Regli L, Held MC, Anderson RE, Meyer FB. Nitric oxide synthase inhibition by L-NAME prevents brain acidosis during focal cerebral ischemia in rabbits. Journal of Cerebral Blood Flow and Metabolism 1996;16:988-95.
68. Rehncrona S, Rosen I, Siesjo BK. Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology. Journal of Cerebral Blood Flow and Metabolism 1981;1:297-311.
69. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
70. Riley RD, Sutton AJ, Abrams KR, Lambert PC. Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present. Journal of Clinical Epidemiology 2004;57:911-24.
71. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 1999;353:376-7.
72. Siesjo BK, Bendek G, Koide T, Westerberg E, Wieloch T. Influence of acidosis on lipid peroxidation in brain tissues in vitro. Journal of Cerebral Blood Flow and Metabolism 1985;5:253-8.
73. Siesjo BK, Katsura K, Kristian T. Acidosis-related damage. Advances in Neurology 1996;71:209-33.
74. Stead LG, Gilmore RM, Bellolio MF, Mishra S, Bhagra A, Vaidyanathan L, et al.Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocritical Care 2009;10(2):181-6.
75. Uyttenboogaart M, Luijckx GJ, Vroomen PC, Stewart RE, De Keyser J. Measuring disability in stroke: relationship between the modified Rankin scale and the Barthel index. Journal of Neurology 2007;254(8):1113-7.
76. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al.Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 2001;345(19):1359-67.
77. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al.Intensive insulin therapy in the medical ICU. New England Journal of Medicine 2006;354(5):449-61.
78. Van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ. Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 1993;24:1129-32.
79. Voll CL, Whishaw IQ, Auer RN. Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in rats. Stroke 1989;20(5):646-51.
80. Voll CL, Auer RN. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. Journal of Cerebral Blood Flow and Metabolism 1991;11(6):1006-14.
81. Vriesendorp TM, DeVries JH, Hulscher JB, Holleman F, Van Lanschot JJ, Hoekstra JB. Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trial. Critical Care 2004;8(6):R437-42.
82. Wass CT, Scheithauer BW, Bronk JT, Wilson RM, Lanier WL. Insulin treatment of corticosteroid-associated hyperglycemia and its effect on outcome after forebrain ischemia in rats. Anesthesiology 1996;84(3):644-51.
83. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997;314:1303-6.
84. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300(8):933-44.
85. Woo E, Ma JT, Robinson JD, Yu YL. Hyperglycemia is a stress response in acute stroke. Stroke 1988;19:1359-64.
86. Zhu CZ, Auer RN. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. Journal of Cerebral Blood Flow and Metabolism 1994;14(2):237-42.
87. Bellolio MF, Gilmore RM, Stead LG. Interventions for controlling hyperglycaemia in acute ischaemic stroke. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005346.pub2]
88. Bellolio MF, Gilmore RM, Stead LG. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD005346.pub3; PUBMED: PMID: 21901697]